Literature DB >> 7076844

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.

T F Deuel, R M Senior, J S Huang, G L Griffin.   

Abstract

The platelet-derived growth factor (PDGF) is shown to be chemotactic for monocytes and neutrophils. Maximum monocyte chemotaxis to PDGF is fully equal to that achieved with C5a and occurs at congruent to 20 ng/ml (congruent to 0.7 nM). Maximum neutrophil chemotaxis is congruent to 60% that achieved with C5A but occurs at congruent to 1 ng/ml (congruent to 32 pM). The chemotactic activity of PDGF is blocked by specific antisera to PDGF and by protamine sulfate, a competitive inhibitor of PDGF binding to cell surfaces. In contrast to PDGF, epidermal growth factor shows no chemotactic activity for inflammatory cells at 0.5-100 ng/ml. The high level of chemotactic activity of PDGF suggests that in addition to its role as a mitogen for smooth muscle cells and fibroblasts, PDGF may be involved in attracting inflammatory cells to sites of platelet release.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076844      PMCID: PMC370161          DOI: 10.1172/jci110509

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  The pathogenesis of atherosclerosis (second of two parts).

Authors:  R Ross; J A Glomset
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

2.  Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion.

Authors:  R N Pinckard; M Halonen; J D Palmer; C Butler; J O Shaw; P M Henson
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

Review 3.  The platelet-derived growth factor.

Authors:  R Ross; A Vogel
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

4.  Increased vascular permeability produced by human platelet granule cationic extract.

Authors:  R L Nachman; B Weksler; B Ferris
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

5.  Response of platelets to tissue injury.

Authors:  M A Packham; E E Nishizawa; J F Mustard
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

6.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Release of permeability factors from the blood platelet.

Authors:  J F Mustard; H Z Movat; D R Macmorine; A Sényi
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

8.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.

Authors:  L A Harker; R Ross; S J Slichter; C R Scott
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more
  109 in total

1.  Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development.

Authors:  J R Crosby; K A Tappan; R A Seifert; D F Bowen-Pope
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity.

Authors:  A L Cook; P M Kirwin; S Craig; L J Bawden; D R Green; M J Price; S J Richardson; A Fallon; A H Drummond; R M Edwards
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

3.  Coexpression of the genes for platelet-derived growth factor B-chain receptor and macrophage colony-stimulating factor 1 receptor during monocytic differentiation.

Authors:  P Pantazis; S Kharbanda; A S Goustin; T Galanopoulos; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.

Authors:  G Rogler; K J Lackner; G Schmitz
Journal:  Basic Res Cardiol       Date:  1995 Nov-Dec       Impact factor: 17.165

5.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.

Authors:  Wiltrud Lederle; Hans-Jürgen Stark; Mihaela Skobe; Norbert E Fusenig; Margareta M Mueller
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Production of platelet-derived growth factorlike protein by rat mesangial cells in culture.

Authors:  H E Abboud; E Poptic; P DiCorleto
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin.

Authors:  P S Frenette; R C Johnson; R O Hynes; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse.

Authors:  D G Greenhalgh; K H Sprugel; M J Murray; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

10.  Human arterial wall cells secrete factors that are chemotactic for monocytes.

Authors:  T Mazzone; M Jensen; A Chait
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.